AnakinraToxidermia follwing off-label treatment: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1751卷 / 1期

关键词：

D O I：

10.1007/s40278-019-61168-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：35 / 35

相关论文

共 50 条

[31] PasireotideHyperglycaemia and off-label use: case report
Reactions Weekly, 2021, 1876 (1) : 273 - 273
[32] RituximabHypogammaglobulinaemia and off-label use: case report
Reactions Weekly, 2023, 1956 (1) : 453 - 453
[33] AntineoplasticsVarious toxicities, treatment failure and off-label use: case report
Reactions Weekly, 2023, 1972 (1) : 50 - 50
[34] ClozapineSyncope and off-label use: case report
Reactions Weekly, 2022, 1930 (1) : 198 - 198
[35] CobimetinibDropped head syndrome following off-label treatment: case report
Reactions Weekly, 2019, 1782 (1) : 110 - 110
[36] TocilizumabIntrauterine fetal demise following off-label treatment: case report
Reactions Weekly, 2022, 1899 (1) : 357 - 357
[37] RufinamideAggravation of atonic seizure during off-label treatment: case report
Reactions Weekly, 2016, 1611 (1) : 151 - 151
[38] Multiple drugsSedation, treatment failure and off-label use: case report
Reactions Weekly, 2021, 1883 (1) : 279 - 279
[39] AzithromycinElevated transaminase levels during off-label treatment: case report
Reactions Weekly, 2021, 1855 (1) : 77 - 77
[40] LinezolidLeukopenia and off-label use: case report
Reactions Weekly, 2025, 2044 (1) : 180 - 180

← 1 2 3 4 5 →